I'd invest $5,000 into these excellent ASX shares for the long term

In my opinion, these three ASX shares look like great long-term ideas.

| More on:
A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • If I were given $5,000 to invest in some long-term growth shares, I know of three I’d like to invest in
  • The VanEck Morningstar Wide Moat ETF would be one of my picks because of its quality holdings
  • Lovisa and Sonic Healthcare both have long-term growth potential in my opinion

I think there are some great-looking opportunities on the ASX share market this month. If I had $5,000 to invest into some ASX shares, there are some investments I'd choose for the long term.

While some investors may be fearful of volatility, I think there are advantages to investing at times like this. The most obvious one is that investors can buy businesses at lower prices. I like the sound of that.

In my opinion, choosing a good investment at a good price can lead to good returns over time. You never know what share prices are going to do next, but I want to jump on the opportunities when I see them.

With that in mind, I would spend $5,000 like this:

VanEck Morningstar Wide Moat ETF (ASX: MOAT) — $2,500

This is an exchange-traded fund (ETF) that is based on investing in US businesses that are deemed to have competitive advantages — or 'economic moats' — that are likely to last for many years into the future.

Economic moats can come in many different forms such as intellectual property, brand power, cost advantages, and so on.

Businesses are only chosen for this ETF's portfolio if Morningstar analysts believe the economic moat will stay strong for at least the next decade and, more likely than not, the second decade as well.

On top of that, businesses are only picked for the portfolio if they are good value compared to Morningstar's estimate of fair value.

At the latest disclosure, these are some of the biggest positions in the portfolio: Lockheed Martin, Bristol-Myers Squibb, Altria, Dominion Energy, and Berkshire Hathaway.

I like the idea of this ETF because of the quality across the board that it offers. It also seems to be consistently invested in businesses that are good value because the portfolio changes to the next opportunities.

Lovisa Holdings Ltd (ASX: LOV) – $1,500

Lovisa is a fast-growing ASX share that sells affordable jewellery in multiple countries. The USA is a particularly promising market for the company, which is why it's working on expanding its store network there.

The business appears to be very scalable, which bodes well for future profitability. In the FY22 half-year result, Lovisa reported that it grew its revenue by 48.3%, while net profit after tax (NPAT) increased by 70.3%.

I think that this ASX share has a compelling future under the new management. There are plenty of other regions that Lovisa can expand to, such as countries in Asia, which will lengthen its growth runway.

Another benefit to the company is that it pays dividends, so shareholders are getting the benefit of the profit generated in the form of cash returns.

I think this ASX share can achieve good compounding for years to come.

Sonic Healthcare Limited (ASX: SHL) – $1,000

Sonic Healthcare is a leading company in the pathology sector. It generates profit from Australia, Europe, and the US – it's globally diversified.

The company benefits from long-term trends such as aging demographics. This is helping it achieve steadily-rising revenue and profit. I like that the business is quite defensive – people need healthcare whether the economy is booming or stuttering.

Sonic Healthcare is also benefiting from the ongoing level of COVID-19 testing. It has been an important player in helping slow the spread of the pandemic. It has made plenty of cash flow from testing, which the company has been putting towards acquisitions to boost long-term earnings. Canberra Imaging is one example of a recent acquisition.

I'm attracted to the ASX share's long-term future, even if it hasn't fallen as much as some other ASX shares in 2022.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Berkshire Hathaway (B shares) and Bristol Myers Squibb. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Dominion Energy, Inc and Lockheed Martin and has recommended the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), short January 2023 $200 puts on Berkshire Hathaway (B shares), and short January 2023 $265 calls on Berkshire Hathaway (B shares). The Motley Fool Australia has recommended Berkshire Hathaway (B shares), Lovisa Holdings Ltd, Sonic Healthcare Limited, and VanEck Vectors Morningstar Wide Moat ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Person pretends to types on laptop drawn in sand.
Opinions

I sold one of my oldest ASX 200 shares last week. Here's why

Why would I sell one of my longest-held stocks?

Read more »

Broker analysing the share price.
Materials Shares

Buy, hold, or sell? Broker's verdict on 3 ASX 200 materials shares

Materials was one of four market sectors that weakened in overall value in FY25.

Read more »

A person sitting at a desk smiling and looking at a computer.
Technology Shares

3 ASX 200 tech shares to buy in July: Experts

The ASX tech sector delivered outstanding returns for investors in FY25.

Read more »

A group of executives sit in front of computer screens in a darkened room while a colleague stands giving a presentation with a share price graphic lit up on the wall
Opinions

2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth

Shaw and Partners portfolio manager James Gerrish says he knows this will be an 'unpopular call'.

Read more »

Woman and man calculating a dividend yield.
Opinions

Buy or bail? Fundie's verdict on 2 ASX 300 shares

Stuart Bromley of Medallion Financial Group provides his insights.

Read more »

A woman sits in a quiet home nook with her laptop computer and a notepad and pen on the table next to her as she smiles at information on the screen.
Opinions

2 top ASX passive income stocks to buy with $5,000 today

I think these leading ASX passive income shares will keep delivering market beating yields in FY 2026.

Read more »

A black cat waiting to pounce on a mouse.
Opinions

ASX All Ords gold share jumps 28% in 7 days – but fundie says don't hold on

Niv Dagan of Peak Asset Management has a sell rating on this ASX All Ords gold stock.

Read more »

a man in a business suit sits at his laptop computer at his desk and smiles broadly in an office setting, giving an air of optimism and confidence.
Opinions

This ASX 200 share has made the most money for my portfolio. I'm expecting a lot more

There’s one key reason why I’m expecting strong growth from this stock.

Read more »